Table 1.
Receptor (Ligand) | Bmax (fmol/mg protein) | |
---|---|---|
Control | Chronic Caffeine |
|
A1-Adenosine | ||
(CHA) | 911 ± 23 | 1089 ± 39** |
(CHA, striatum) | 688 ± 14 | 767 ± 28** |
A2A-Adenosine | ||
(CGS 21680, striatum) | 872 ±57 | 884 ± 44 |
α1-Adrenergic | ||
(Cionidinc) | 175 ± 7 | 189 ± 12 |
α2-Adrenergic | ||
(Prazosin) | 200± 3 | 193 ± 2 |
β1-Adrenergic | ||
(DHA) | 224± 9 | 167 ± 5* |
β1-Adrenergic | ||
(DHA, cerebellum) | 158 ± 12 | 115 ± 11* |
D1-Dopamine | ||
(SCH 23390, striatum) | 3097 ± 81 | 3165 ± 66 |
D2-Dopamine | ||
(Spipcrone, striatum)‡ | 729 ± 21 | 725 ±55 |
5-HT1 | ||
(Serotonin) | 361 ± 14 | 474 ± 48** |
5-HT2 | ||
(Ketanserin) | 275 ± 11 | 347 ±11* |
Nicotinic | ||
(Nicotine) | 34 ± 2 | 50 ± 3* |
(Nicotine, striatum) | 37 ± 1 | 39 ± 2 |
Muscarinic | ||
(Quinuclidinyl benzilate) | 1153 ±56 | 1509 ± 47** |
NMDA | ||
(MK-801) | 2653 ± 97 | 2588 ± 46 |
GABAA | ||
(Diazepam) | 1061 ± 69 | 1741 ± 100* |
Opioid | ||
mu (DAMGO) | 119 ± 6 | 134 ± 5 |
delta (DPDPE) | 83 ±2 | 104 ± 7** |
kappa (U69593) | 339 ± 65 | 230± 48 |
Sigma | ||
(DTG) | 2580± 90 | 2560± 170 |
Ca2+ Channel | ||
(Nitredinine} | 314 ± 6 | 369 ± 12** |
Binding of radioligands to conical membranccs or as noted to cerebellar or striatal mcmbr.ances from control mice and chronic caffeine mice. Values for Bmax are means ± S.E.M. (Shi et al., 1993, 1994).
p<0.01
p<0.05.
no significant change when assayed with [3H] raclopride.